Home › Trial NCT05891171
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
- Trial IDNCT05891171
- StatusActive Not Recruiting
- PhasePhase 1
- Study typeInterventional
- SponsorArcus Biosciences, Inc.
- Enrollment40
- Start date2023-10-13
- ConditionsAdvanced Cancer · Advanced Malignancies · Bladder Cancer · Cervical Cancer · Esophageal Cancer · Gastric Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.